Kyoko Miyamoto

2PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 07, 2026
Docirbrutinib is a pan-mutant BTK inhibitor and inhibits B-cell receptor signaling in chronic lymphocytic leukemia cells in preclinical and early clinical investigations.

|Nov 11, 2024
Safety, pharmacokinetics, and pharmacodynamics of sofnobrutinib, a novel non-covalent BTK inhibitor, in healthy subjects: First-in-human phase I study.

Kyoko Miyamoto, Robert M Miller, Christine Voors-Pette

Pageof 1

Frequent Collaborators

2 joint publications

Masaaki Sawa

1 joint publications

Robert M Miller

1 joint publications

Jart A F Oosterhaven

1 joint publications

Katsuhiro Mihara